Skip to content
10-Q

Quarterly Report

Cellcyte Genetics Corp.

0001056520-14-000086

← back to feed
Filed
May 16, 2014 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2014 · May 13, 2014 82.33M sh
Operating Cash Flow Q1 2014 · Mar 31, 2014 −$12.81K
Operating Cash Flow Q1 2014 · Mar 31, 2014 −$5.98M
Operating Cash Flow Q1 2014 · Mar 31, 2013 −$9.84K
Stockholders Equity Q1 2014 · Mar 31, 2014 −$852.59K
Stockholders Equity Q1 2014 · Mar 31, 2013 −$819.8K
Current Liabilities Q1 2014 · Mar 31, 2014 $337.69K
Current Liabilities restated Q1 2014 · Mar 31, 2013 $351.34K
Total Liabilities Q1 2014 · Mar 31, 2014 $853.58K
Total Liabilities Q1 2014 · Mar 31, 2013 $828.83K
Current Assets Q1 2014 · Mar 31, 2014 $993
Current Assets restated Q1 2014 · Mar 31, 2013 $9.03K
Total Assets Q1 2014 · Mar 31, 2014 $993
Total Assets restated Q1 2014 · Mar 31, 2013 $9.03K
Sga Expense Q1 2014 · Mar 31, 2014 $12.05K
Sga Expense Q1 2014 · Mar 31, 2014 $2.68M
Sga Expense Q1 2014 · Mar 31, 2013 $12.46K
Rd Expense Q1 2014 · Mar 31, 2014 $1.3M
Net Income Q1 2014 · Mar 31, 2014 −$32.79K
Net Income Q1 2014 · Mar 31, 2014 −$12.72M
Net Income Q1 2014 · Mar 31, 2013 −$35.27K